Dermatitis Research Today is a free monthly online journal that collates and summarizes the latest research about Dermatitis, including details on contact-, seborrheic-, atopic-, allergic-dermatitis, treatment.

Results of patch testing to a corticosteroid series: a retrospective review of 1188 patients during 6 years at Mayo Clinic.

Davis MD, el-Azhary RA, Farmer SA

Department of Dermatology, Mayo Clinic, Rochester, Minnesota 55905, USA.

BACKGROUND: Allergy to topical corticosteroids is more common than previously realized. To detect this allergy, a corticosteroid series is used for patch testing in addition to corticosteroid screens on a standard series. OBJECTIVE: We sought to review our experience with patch testing to corticosteroid series. METHODS: We conducted a retrospective study of patch testing to our corticosteroid series over 6 years (January 1, 2000-December 31, 2005). RESULTS: Of 1188 patients patch tested to corticosteroid series, 127 (10.69%) had allergic reaction to at least one corticosteroid; 56 reacted to multiple corticosteroids. Rates of allergic patch test reaction to 19,611 individual corticosteroids were 0.41% to 5.03%. Rates of reaction to corticosteroid groups were 1.10% to 5.72%; concomitant reactions between groups were noted. Present screens on our standard series identified 74% of those detected on the corticosteroid series; tixocortol pivalate alone detected less than 50%. LIMITATIONS: Limitations include that this study was retrospective and the possible interobserver variation in interpretation of patch tests. CONCLUSION: In patients suggested to have corticosteroid allergy, patch testing confirms allergy in 10.69%; allergy is often to multiple corticosteroids and across groups. Screens on a standard series may detect 74% of those detected on a corticosteroid series.

Published 16 May 2007 in J Am Acad Dermatol, 56(6): 921-7.
Full-text of this article is available online (may require subscription).

© 2004-2008 Dermatitis Research Today. All Rights Reserved.